Nanobusiness News RSS Feed - Nanobusiness

ProLynx Obtains US Patent 8,703,907 Covering Controlled Drug Release from Dendrimer Conjugates

ProLynx Obtains US Patent 8,703,907 Covering Controlled Drug Release from Dendrimer Conjugates

ProLynx LLC, a biotechnology company focused on development of disruptive drug delivery systems for half-life extension of injectable drugs today announced that the United States Patent and Trademark Office has issued US Patent 8,703,907 covering controlled release of drugs from dendrimer conjugates over prolonged periods. [More]
Cheap Tubes Shifts into New 16,000-Square-Foot Production Facility in Vermont

Cheap Tubes Shifts into New 16,000-Square-Foot Production Facility in Vermont

Cheap Tubes is please to announce the completion of their move into their new 16,000SF manufacturing facility. Out initial search was long and building renovation are ongoing but we have gotton to the point where we could move all of our operations under 1 roof to better serve our customers. [More]
Quorum Technologies is Proud to Receive the Queen's Award for Enterprise

Quorum Technologies is Proud to Receive the Queen's Award for Enterprise

Quorum Technologies is proud to receive the Queen’s Award for International Trade. This major accolade is the result of an impressive export drive by the company - increasing overseas sales by 72% over three years and selling 92% of its production overseas. [More]
PI's P-763 XY Nanopositioning Stage - New and Affordable Piezo Stage Positioner

PI's P-763 XY Nanopositioning Stage - New and Affordable Piezo Stage Positioner

PI's P-763 XY nanopositioning stage is a new, more affordable addition to PI's wide range of piezo stage positioners. [More]
Graphene NanoChem Subsidiary Signs Heads of Agreement for JV with Emery Advanced Materials

Graphene NanoChem Subsidiary Signs Heads of Agreement for JV with Emery Advanced Materials

Graphene NanoChem, the performance nanochemicals and advanced materials company, is pleased to announce that Platinum NanoChem Sdn Bhd, its wholly-owned subsidiary has signed a heads of agreement for a joint venture collaboration (“Joint Venture”) with Emery Advanced Materials (“Emery”), a subsidiary of Emery Oleochemicals Sdn Bhd., focused on developing a new generation of speciality chemicals for plastic additives, biolubricants and rubber. [More]
Platinum NanoChem Enters JV with Scomi Oiltools

Platinum NanoChem Enters JV with Scomi Oiltools

Graphene NanoChem, the performance nanochemicals and advanced materials company, is pleased to announce that Platinum NanoChem Sdn Bhd, its wholly-owned subsidiary has entered into a joint venture (“JV”) with Scomi Oiltools Sdn Bhd (“Scomi Oiltools”) to produce and supply a range of speciality chemicals, including PlatDrill and other graphene-enhanced green chemicals, exclusively for the oilfield chemicals market. [More]
DNP Photomask Technology Taiwan Merges into Photronics Semiconductor Mask Corporation

DNP Photomask Technology Taiwan Merges into Photronics Semiconductor Mask Corporation

Photronics, Inc., a worldwide leader in supplying innovative imaging technology solutions for the global electronics industry, today announced the successful closing of the previously announced joint venture with Dai Nippon Printing Co., Ltd. (DNP) (7912:Tokyo Stock Exchange). [More]
RBCC Positions Itself on Front Lines of a Bioprinting Revolution

RBCC Positions Itself on Front Lines of a Bioprinting Revolution

By substantially increasing its investment in biotech innovators Nano3D Biosciences, Rainbow Coral Corp. has positioned itself on the front lines of a bioprinting revolution poised to forever alter the possibilities of healthcare. [More]
Investment in Graphene as a Futures Commodity

Investment in Graphene as a Futures Commodity

What does a simple pencil have in common with the Nobel Prize winning discovery that’s expected to be the world’s next big game-changer? [More]
Baxter to Acquire Chatham’s Hemophilia Developmental Gene Therapy Programs

Baxter to Acquire Chatham’s Hemophilia Developmental Gene Therapy Programs

Baxter International Inc. and Chatham Therapeutics, LLC, today announced that Baxter has agreed to acquire all of Chatham’s outstanding membership interests. As a result of the transaction, Baxter will acquire Chatham’s developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia. [More]
Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions